http://www.halozyme.com
Halozyme Therapeutics, Inc. Company Intro
Industry
Healthcare
Halozyme Therapeutics, Inc. Headquaters
11388 Sorrento Valley Road
San Diego,92121
United States
Halozyme Therapeutics, Inc. Share price
14 Sep 2022 09:24 GMT
$40.94
-1.06 (-2.52 %)
Halozyme Therapeutics, Inc. Market cap
$5.815 B
WMC RANKING
2023
Halozyme Therapeutics, Inc. # 36
BiotechnologyLatest Halozyme Therapeutics, Inc. News
07 Feb 2023
Pertuzumab Market report by growth enablers, geography ...
Key players are Halozyme Therapeutics, Inc. and F. Hoffmann-La Roche Ltd. The Pertuzumab Market Industry research forecast to 2023-2030 provides detailed...
07 Feb 2023
Halozyme to Report Fourth Quar
7, 2023 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) ("Halozyme") today announced it will release its fourth quarter and full year 2022...
07 Feb 2023
Pertuzumab Market report by growth enablers, geography ...
Key players are Halozyme Therapeutics, Inc. and F. Hoffmann-La Roche Ltd. The Pertuzumab Market Industry research forecast to 2023-2030 provides detailed...
WMC Market Score
WMC Market to Revenue Score
Halozyme Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Halozyme Therapeutics, Inc. | USD | $331,262 | $77,250 | $163,083 | $58,150B | 36 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,197,600 | $3,997,800 | $4,003,800 | $754,300B | 1 |
| Vertex Pharmaceuticals Incorporated | USD | $6,414,881 | $2,617,257 | $2,762,032 | $713,610B | 2 |
| Alexion Pharmaceuticals, Inc. | USD | $6,261,601 | $2,747,200 | $681,800 | $ | 3 |
| Incyte Corporation | USD | $2,702,913 | $2,048,306 | $478,480 | $150,520B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Halozyme Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Post vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Halozyme Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Halozyme Therapeutics, Inc. | 3.60 | 6.55 | 0.00 | 0 | 0 | 0 | 2.96 |
| Regeneron Pharmaceuticals, Inc. | 100 | 25.50 | 16.15 | 22 | 0 | 0 | 28.52 |
| Vertex Pharmaceuticals Incorporated | 69.75 | 35.68 | 8.95 | 33 | 0 | 0 | 34.78 |
| Alexion Pharmaceuticals, Inc. | 68.08 | 100 | 100 | 22 | 0 | 0 | 100 |
| Incyte Corporation | 29.39 | 5.03 | 0.04 | 100 | 0 | 0 | 47.37 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
